Your browser doesn't support javascript.
loading
Incidence and Clinical Outcomes of New-Onset Atrial Fibrillation in Critically lll Patients with COVID-19: A Multicenter Cohort Study - New-Onset Atrial Fibrillation and COVID-19.
Kensara, Raed; Aljuhani, Ohoud; Korayem, Ghazwa B; Alkofide, Hadeel; Almohareb, Sumaya N; Alosaimi, Yousef S; Altebainawi, Ali F; Bin Saleh, Khalid; Andas, Norah Al; Harbi, Shmeylan Al; Harthi, Abdullah F Al; Ashkan, Uhood; Alghamdi, Rema; Badreldin, Hisham A; Hafiz, Awatif; AlFaifi, Mashael; Alqahtani, Rahaf A; Vishwakarma, Ramesh; Alenazi, Abeer A; Alalawi, Mai; Mahboob, Reem; Alfouzan, Renad A; Al Tuhayni, Layan B; Qahtani, Nouf Al; Sulaiman, Khalid Al.
Afiliação
  • Kensara R; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Aljuhani O; Pharmaceutical Care Department, 48168King Abdulaziz Medical City, Jeddah, Saudi Arabia.
  • Korayem GB; Department of Pharmacy Practice, Faculty of Pharmacy, 37848King Abdulaziz University, Jeddah, Saudi Arabia.
  • Alkofide H; Department of Pharmacy Practice, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
  • Almohareb SN; College of Pharmacy, 37850King Saud University, Riyadh, Saudi Arabia.
  • Alosaimi YS; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Altebainawi AF; College of Pharmacy, 48149King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Bin Saleh K; Pharmaceutical Services Department, King Saud Medical City, Riyadh, Saudi Arabia.
  • Andas NA; College of Pharmacy, 204570Shaqra University, Sahqra, Saudi Arabia.
  • Harbi SA; Pharmaceutical Care Services, King Salman Specialist Hospital, Hail Health Cluster, Hail, Saudi Arabia.
  • Harthi AFA; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Ashkan U; College of Pharmacy, 48149King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Alghamdi R; Pharmaceutical Services Department, King Saud Medical City, Riyadh, Saudi Arabia.
  • Badreldin HA; Pharmaceutical Services Department, King Saud Medical City, Riyadh, Saudi Arabia.
  • Hafiz A; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • AlFaifi M; College of Pharmacy, 48149King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Alqahtani RA; Pharmaceutical Services Department, King Saud Medical City, Riyadh, Saudi Arabia.
  • Vishwakarma R; Pharmaceutical Services Department, King Saud Medical City, Riyadh, Saudi Arabia.
  • Alenazi AA; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Alalawi M; Pharmaceutical Care Department, 48168King Abdulaziz Medical City, Jeddah, Saudi Arabia.
  • Mahboob R; Pharmaceutical Care Department, 48168King Abdulaziz Medical City, Jeddah, Saudi Arabia.
  • Alfouzan RA; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Al Tuhayni LB; College of Pharmacy, 48149King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Qahtani NA; Pharmaceutical Services Department, King Saud Medical City, Riyadh, Saudi Arabia.
  • Sulaiman KA; Department of Pharmacy Practice, Faculty of Pharmacy, 37848King Abdulaziz University, Jeddah, Saudi Arabia.
Clin Appl Thromb Hemost ; 29: 10760296231156178, 2023.
Article em En | MEDLINE | ID: mdl-36789786

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article